Furthermore, four tumours harboured KRAS somatic mutations that have been previously shown to have a tendency toward mutual exclusivity with RASSF1a promoter methylation in colorectal and non-small cell lung cancers [39, 40]. The gene discussed is RASSF1; the disease is neoplasm.